Internal Medicine, Infectious Disease · Colorado Springs, CO
NPI
1891713731
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3230 E Woodmen Rd Ste 210
Colorado Springs, CO, 80920
Phone (719) 578-5176
Groups this clinician bills Medicare through
Medicare paid, 2024
$126K
76,308 services
Medicare patients, 2024
334
Average age 72
Drug cost, 2024
$697K
693 prescriptions
Company payments, 2025
$330
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elizabeth A Kleiner was code J0878 (injection, daptomycin, 1 mg), 71,300 times for 24 patients. In total Elizabeth A Kleiner billed 76,308 services in 28 codes, and Medicare paid $126K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 71,300 | 24 | $0.04 | $3,118 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 1,716 | 33 | $0.36 | $615 |
| 96365 Intravenous Infusion, Hydration | Office | 531 | 79 | $55.03 | $29K |
| 99232 Hospital E&M - Subsequent | Facility | 425 | 138 | $66.05 | $28K |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 278 | 20 | $9.00 | $2,502 |
| 99213 Office E&M - Established | Office | 206 | 101 | $77.94 | $16K |
| 99222 Hospital E&M - Initial | Facility | 108 | 99 | $104.53 | $11K |
| 96367 Intravenous Infusion, Hydration | Office | 77 | 13 | $24.80 | $1,910 |
| 99233 Hospital E&M - Subsequent | Facility | 76 | 53 | $97.35 | $7,399 |
| 99214 Office E&M - Established | Office | 68 | 44 | $107.26 | $7,293 |
| 99223 Hospital E&M - Initial | Facility | 51 | 50 | $143.04 | $7,295 |
| 36415 Venipuncture Blood Collection | Office | 29 | 22 | $8.05 | $234 |
| 99204 Office E&M - New | Office | 18 | 18 | $143.33 | $2,580 |
| 99205 Office E&M - New | Office | 16 | 16 | $177.85 | $2,846 |
| 99221 Hospital E&M - Initial | Facility | 11 | 11 | $69.50 | $765 |
By year: 2022 $108K for 79,740 services; 2023 $108K for 71,301 services; 2024 $126K for 76,308 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 29 | 22 | $8.05 | $234 |
Medicare prescription drug claims, 2024
In 2024, the drug Elizabeth A Kleiner prescribed most often to Medicare patients was Cefadroxil, with 98 prescriptions and refills. In total Elizabeth A Kleiner wrote 693 Medicare prescriptions that cost $697K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cefadroxil Generic | 98 | 236 | 39 | $5,675 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 83 | 83 | Under 11 | $356K |
| Amoxicillin Generic | 63 | 115 | 17 | $1,466 |
| Descovy Emtricitabine/Tenofov Alafenam | 43 | 43 | Under 11 | $99K |
| Ceftriaxone Ceftriaxone Sodium | 39 | 39 | Under 11 | $3,544 |
| Daptomycin Generic | 34 | 34 | Under 11 | $16K |
| Cefazolin Sodium Generic | 34 | 34 | Under 11 | $1,694 |
| Prezcobix Darunavir/Cobicistat | 24 | 24 | Under 11 | $64K |
| Isentress Hd Raltegravir Potassium | 24 | 24 | Under 11 | $52K |
| Nystatin Generic | 19 | 19 | Under 11 | $301 |
| Doxycycline Hyclate Generic | 18 | 32 | Under 11 | $659 |
| Ertapenem Ertapenem Sodium | 17 | 17 | Under 11 | $4,560 |
| Cefdinir Generic | 15 | 15 | Under 11 | $532 |
| Cephalexin Generic | 14 | 32 | Under 11 | $494 |
| Nevirapine Er Nevirapine | 13 | 13 | Under 11 | $919 |
Brand drugs: 197 claims; generic drugs: 496 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elizabeth A Kleiner $330 ($330 in general payments such as food, travel and fees) from 7 companies. The largest payer was ViiV Healthcare Company with $102.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.